Twitter Beğeni Hilesi

It's a must-see! If you are particularly interested in the topic, you should definitely go to our Journal's website 🤩 🔗atherosclerosis-journal.com/action/doSearc… #EASSoMe Elsevier Cardiology #CvPrev

Do you recognize the illustration on the cover of the Augusto Issue of our Journal? 🕵️ It is taken from the original article by Danielle Mullis et al. If you missed it, read it today! 🔗 atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Elsevier Cardiology #EASSoMe #CvPrev

⚠️ Clinical trials testing therapeutic strategies to decrease EAT may be warranted in the management of coronary microvascular disease 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Nidhi Patel Carlo N. De Cecco, MD, PhD Ashish Sharma Emory IM Chiefs Elsevier Cardiology #EASSoMe

These data advanced our knowledge about the interactions between HDL and diabetes 👇 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society International Atherosclerosis Society (IAS) Elsevier Cardiology #EASSoMe #CvPrev

CRISPR/Cas9-mediated suppression of A4GALT rescues endothelial cell dysfunction in a fabry disease vasculopathy model derived from human induced pluripotent stem cells 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Elsevier Cardiology #CvPrev #EASSoMe

This study has pinpointed several independent risk factors linked to the onset of carotid ath in the Chinese physical examination population. These factors include age, DBP, SUA, LDL-C, and HDL-C 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Elsevier Cardiology #EASSoMe #CVPrev

• Increasing awareness in 🧑‍⚕️👩‍⚕️ about women's unique CV care needs can address sex differences • The ultimate goal is to ensure 👬 and 👭 get equitable, effective CHD care, tailored to their needs and risks 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Raffaele Bugiardini

This is an incredible open access Primary Prevention advice - Just about the best I have seen. ApoB oriented, no specific TG goal - although they should be tested or for sure no HDL-C goal. None of the absolute high-intensity statin silliness for primary prevention

Heterogeneity exists in subclinical ath across LDL-C, CAC and estimated 🫀 risk levels. The value of CCTA in risk-stratifying asymptomatic 👫 could be explored further 🔗atherosclerosis-journal.com/article/S0021-… Khurram Nasir Reed Mszar Miguel Cainzos-Achirica Michael D. Shapiro Jonathan Fialkow Sadeer Al-Kindi, MD

Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets 🔗atherosclerosis-journal.com/article/S0021-… Katie Hanford Annette Neele Liffert Vogt Vascular Metabolism and Inflammation Lab Marc Hilhorst European Atherosclerosis Society Elsevier Cardiology #CvPrev #EASSoMe

Monocitos, AAV y riesgo CV Los monocitos se activan durante la vasculitis asociada a ANCA (AAV) activa y alteran los marcadores relacionados con el metabolismo lipídico. Los monocitos AAV tienen una capacidad intrínseca de adhesión y migración normal, aunque es probable que la

Great analysis of HDL-p size and CHD risk with and without DM Large HDL-p often associated with protection, though smaller HDLp doing most of the efflux — strikes me as strange because large should be doing uptake in periphery — question for LipoFan John Kastelein Sam Tsimikas

🔰Avances en la estratificación del RCV y las estrategias de gestión en la prevención CV primaria ✅️El reconocimiento de la aterosclerosis subclínica y la progresión de la placa como un determinante crítico del riesgo cardiovascular sugiere la necesidad de un cambio de

Targeting the lipoprotein to glycosaminoglycan interaction may lead to novel therapeutic approaches for atherosclerosis 🔗atherosclerosis-journal.com/article/S0021-… Hirushi Kumarapperuma Danielle Kamato Griffith University European Atherosclerosis Society Elsevier Cardiology #EASSoMe #CvPrev

HDL, reverse cholesterol transport, and atherosclerosis: Unravelling the complexity or adding to the confusion? 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society International Atherosclerosis Society (IAS) #EASSoMe Elsevier Cardiology #CvPrev

Macrophages regulate plaque progression in diabetic Apoe-/- mice dependent on Pi4p/Nlrp3 signaling pathway 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Elsevier Cardiology #CvPrev #EASSoMe

Long-term fasting not only maintains lipoprotein functionality but also contributes to a favorable shift in the atherogenic risk profile, which persists even after food reintroduction 🔗atherosclerosis-journal.com/article/S0021-… Robin Mesnage Françoise Wilhelmi de Toledo European Atherosclerosis Society Elsevier Cardiology #EASSoMe

Do you agree? Will it happen? Please note that this is merely a proposal at this stage. Seba GZ, MD, MSc thanks for your help with this. 🥂 Atherosclerosis

Tobacco smoking is associated with sex- and plaque-type specific upregulation of CRLF1 in atherosclerotic lesions 🔗atherosclerosis-journal.com/article/S0021-… michal mokry Finnish Atherosclerosis Society (SATY ry) Mete Civelek European Atherosclerosis Society Elsevier Cardiology #CvPrev #EASSoMe

The investigation of the region-specific lipid composition of symptomatic and asymptomatic human ath plaques reveals specific lipid markers of plaque outcome which could be linked to known biological characteristics of stable plaques 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society